Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1ASK Nr. 21972----[1] 5
2Atazanavir (ATV) + ritonavir (RTV), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (NRTIs)[2] Atazanavir,
Ritonavir		[3] D00427 ,
D01276 ,
D07471 		--[1] 265
3Continuation of current HAART (boosted protease inhibitor [PI] combination + 2 NRTIs)----[1] 265
4NR----[1] 299
5NR082 injection----[1] 302
6NR2B NMDA Antagonist CP-101,606 (traxoprodil)[1] Ketamine[2] D00711 ,
D08098 		[5] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		[20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[1] 6
7NRTX-1001----[1] 141
8Scorpio NRG posterior stabilized (PS)----[1] 46